CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-16 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,577 | $8.37 | $13K | 29,867 |
| 2024-01-16 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −2,813 | 11,251 | ||
| 2023-10-16 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +20,835 | 93,685 | ||
| 2023-10-16 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −8,851 | $3.57 | $32K | 84,834 |
| 2023-10-16 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −20,835 | 104,172 | ||
| 2023-10-16 | BILINSKY IGOR Chief Operating Officer | Option exercise | +2,813 | 30,026 | ||
| 2023-10-16 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,395 | $3.57 | $5K | 28,631 |
| 2023-10-16 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −2,813 | 14,064 | ||
| 2023-10-16 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +2,813 | 33,766 | ||
| 2023-10-16 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,395 | $3.57 | $5K | 32,371 |
| 2023-10-16 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −2,813 | 14,064 | ||
| 2023-09-18 | MCPEAK MERRILL A Director | Purchase | +10,000 | $5.56 | $56K | 248,633 |
| 2023-09-15 | Rothbaum Wayne P. Director | Purchase | +5,000,000 | $5.30 | $26.5M | 23,067,333 |
| 2023-07-14 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +20,834 | 81,701 | ||
| 2023-07-14 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −8,851 | $7.76 | $69K | 72,850 |
| 2023-07-14 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −20,834 | 125,007 | ||
| 2023-07-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +2,813 | 32,348 | ||
| 2023-07-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,395 | $7.76 | $11K | 30,953 |
| 2023-07-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −2,813 | 16,877 | ||
| 2023-07-14 | BILINSKY IGOR Chief Operating Officer | Option exercise | +2,813 | 28,608 |
Page 17 of 23 · 446 trades